Long term follow-up of children with mixed connective tissue disease

Lupus

Volumn 5, Issue 3, 1996, Pages 221-226

  Mier, R ^a   Ansell, B ^a   Hall, M A ^a   Hasson, N ^a   Levinson, J ^a   Lovell, D ^a   Passo, M ^a   Rennebohm, R ^a   Woo, P ^a  

^a Shriners Hospital for Children   (United States)

Author keywords

Mixed connective tissue disease; Overlap syndrome; RNP antibodies; Undifferentiated connective tissue disease

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE;

EID: 0029951774     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500310     Document Type: Article

References (41)

1. Kasukawa R et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (ed) Mixed connective tissue disease and antinuclear antibodies. Elsevier; Amsterdam; 1987; 41-47.
2. Sharp GC et al. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 1972; 52: 148-159.
3. Yokota S. Mixed connective tissue disease in childhood. Acta Paediatrica Japonica 1993; 35: 472-479.
4. Tiddens HAWM et al. Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr 1993; 122: 191-197.
5. Oetgen WJ, Boice JA, Lawless OJ. Mixed connective tissue disease in children and adolescents. Peas 1981; 67: 333-337.
6. de Rooij, Fiselier T, van de Putte LB, van Venrooij WJ. Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data. Scand J Rheumatol 1989; 18: 157-160.
7. Allen RC, St-Cyr C, Maddison PJ, Ansell BM. Overlap connective tissue syndromes. Arch Dis Child 1986; 61: 284.
8. Rosental M. Sharp-syndrom bei kindern. Helv Paediat Acta 1978; 33: 251-258.
9. Fraga A et al. Mixed connective tissue disease in childhood. Am J Dis Child 1978; 132: 263-265.
10. 1. J Pediatr 1983; 102: 841-846.
11. Singsen BH, et al. Mixed connective tissue disease in childhood: a clinical and serologic survey. J Pediatr 1977; 90: 893-900.
12. Eberhardt K, Svantesson H, Svensson B. Follow-up study of 6 children presenting with a MCTD-like syndrome. Scand J Rheumatol 1981; 10: 62-64.
13. Baldassare A, Weiss T, Auclair R, Suckner J. Mixed connective tissue disease (MCTD) in children. Arthritis Rheum 1976; 19: 788.
14. 1-70-kd autoantibody-positive mixed connective tissue disease in children: a longitudinal clinical and serologic analysis. Arthritis Rheum 1993; 36: 1599-1602.
15. Black C, Isenberg DA. Mixed connective tissue disease - goodbye to all that. B J Rheum 1992; 31: 695-700.
16. Lazaro MA et al. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 1989; 68: 58-65.
17. 1RNP complex. J Immunol 1990; 145: 630-635.
18. Rasmussen EK et al. Clinical implication of ribonucleoprotein. Arch Dermatol 1987; 123d: 601-605.
19. Nimelstein SH, Brody S, McShane D, Holman MR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 1976; 59: 239-248.
20. Piirainen HI, Kurki PT. Clinical and serological follow-up of patients and polyarthritis, Raynaud's phenomenon, and circulating RNP antibodies. Scand J Rheumatol 1990; 19: 51-56.
21. Alpert MA et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983; 68: 1182-1188.
22. Luhrmann R, Kastner B, Bach M. Structure of spliceosomal snRNPs and their role in pre-mRNA splicing. Biochim Biophys Acta 1990; 1087: 265-292.
23. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 52: 148-159.
24. Hoffman RW, Sharp GC. Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? J Rheumatol 1995; 22: 586-589.
25. Williamson GG, Pennebaker J, Boyle JA. Clinical characteristics of patients with rheumatic disorders who possess antibodies against ribonucleoprotein particles. Arthritis Rheum 1983; 26: 509-515.
26. Habets WJ et al. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983; 54: 265-276.
27. Pettersson I et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1986; 29: 986-996.
28. Hoffman RW et al. Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum 1990; 33: 666-673.
29. McHugh N, James I, Maddison P. Clinical significance of antibodies to a 68 kD U1RNP polypeptide in connective tissue disease. J Rheumatol 1990; 17: 1320-1328.
30. deRooij DJ et al. Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow-up of 18 patients. Ann Rheum Dis 1990, 49: 391-395.
31. Reichlin M, van Venrooij WJ. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1991; 83: 286-290.
32. Sharp GC. Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (ed) Mixed connective tissue diseases and anti-nuclear antibodies. Amsterdam: Elsevier, 1987: 41-47.
33. Black CM, Maddison PJ, Welsh KI, Bernstein R, Boodrow JC, Pereira RS. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum 1988; 31: 131-134.
34. Ruuska P et al. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 52-55.
35. Genth E et al. HLA-DR4 and Gm (1, 3; 5, 21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis, 1987; 46: 189-196.
36. Olsen ML, Arnett FC, Reveille JD. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 94-103.
37. Smolen JS et al. HLA-DR antigens in systemic lupus erythetnatosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis, 1987; 46: 457-462.
38. Kaneoka H et al. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70kd autoantibody positive connective tissue disease patients. Arthritis Rheum 1992; 31: 811-817.
39. Lundberg I et al. Clinical manifestations and anti-(U1) snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Brit J Rheum 1992; 31: 811-817.
40. O'Brien RM et al. T-cell epitopes on the 70kDa protein of the (U1) RNP complex in autoimmune rheumatologic disorders. J Autoimmun 1990; 3: 747-757.
41. Steinbroker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-662.